Author:
Neurauter G.,Jenny M.,Schröcksnadel K.,Ledochowski M.,Fuchs D.,Roth Erich,Oehler Rudolf,Allerberger Franz,Pichler Juliane,Öhlinger Richard,Gelpi Ellen,Budka Herbert,Lass-Flörl Cornelia
Reference63 articles.
1. Benamouzig R, Uzzan B, Little J, Chaussade S (2005) Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer. Curr Top Med Chem 5:493–503
2. Bodaghi B, Goureau O, Zipeto D, Laurent L, Virelizier JL, Michelson S (1999) Role of IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol 162:957–964
3. Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A (2006) Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 12:1144–1151
4. Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM (1989) Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2. Cancer Res 49:4941–4944
5. Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM, Malone DG (1991) Implications of interferon-induced tryptophan catabolism in cancer, autoimmune diseases and AIDS. Adv Exp Med Biol 294:425–435